JEFFREY WEEDEN: Open Payments
NPI 1972539286 · MYRTLE BEACH, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$468 in 23 payments from 9 companies in 2025. Trend: 2023 $236 · 2024 $771 · 2025 $468
Food & beverage: $468
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $113 |
| Novartis Pharmaceuticals Corporation | 6 | $111 |
| CVRx, Inc. | 4 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48 |
| Amgen Inc. | 2 | $38 |
| PFIZER INC. | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| Boston Scientific Corporation | 1 | $19 |
Products named: ELIQUIS, LEQVIO, Barostim Neo System, JARDIANCE, REPATHA, AMVUTTRA, CDS - MCT/CEM Monitoring, CAMZYOS.
Industry payments across SC — which companies pay providers there.
